Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Austrian Science Fund (AW012321 MolTag)
Innovative Medicines Initiative 2 (777365)
- License Information
-
More Information
Article History
Received: 26 December 2021
Accepted: 31 July 2022
First Online: 13 August 2022
Declarations
:
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
